100 %There was a statistically significant reduction in support for defaulter tracking after the PEPFAR policy change (100% vs. 44%, p < 0.01).
NigeriaVIH/sidaobservé October 2014–September 2015publié 2019PloS onePubMeddocument de 11 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 729 evidences · page 62 / 70
100 %There was a statistically significant reduction in support for defaulter tracking after the PEPFAR policy change (100% vs. 44%, p < 0.01).
NigeriaVIH/sidaobservé October 2014–September 2015publié 2019PloS onePubMeddocument de 11 observations
60 %Among 342 men who have sex with men (MSM) in Nigeria, 60% were HIV-infected.
NigeriaVIH/sidapublié 2020Papillomavirus research (Amsterdam, Netherlands)PubMeddocument de 19 observations
95,1 %95.1% of female sex workers who died from HIV/AIDS were not taking antiretrovirals at the time of their death.
NigeriaVIH/sidaobservé 2022-02-01 to 2023-02-28publié 2026International journal of environmental research and public healthPubMeddocument de 10 observations
26 041 inhabitantsDuring April 2019–September 2020, the total number of people living with HIV on antiretroviral therapy supported by PEPFAR statewide in Rivers State increased by 3.8 times, from 26,041 to 99,733.
NigeriaVIH/sidaobservé April 2019–September 2020publié 2021AIDS (London, England)PubMeddocument de 3 observations
445 deathsA total of 445 female sex workers died from HIV/AIDS among those reported by 853 female sex workers in Kenya, Nigeria, and the Democratic Republic of the Congo.
Kenya · Nigeria · RDCVIH/sidaobservé 2022-02-01 to 2023-02-28publié 2026International journal of environmental research and public healthPubMeddocument de 10 observations
22,2 %Among patients who achieved target CD4 cell counts ≥ 500 cells/ml, there was further increase of between 22.2% and 34.1% compared to baseline values.
NigeriaVIH/sidapublié 2024African health sciencesPubMeddocument de 3 observations
22,7 %Of 4,250 patients enrolled, 965 were identified as lost to follow-up, giving a loss to follow-up rate of 22.7%.
NigeriaVIH/sidaobservé August 2008 to July 2018publié 2023West African journal of medicinePubMeddocument de 8 observations
59 %The proportion of people living with HIV/AIDS initiating antiretroviral treatment who were found in the community increased from 59% to 75% during February–September 2020.
NigeriaVIH/sidaobservé February–September 2020publié 2021AIDS research and therapyPubMeddocument de 6 observations
3,55 mmThe mean optic nerve sheath diameter (ONSD) value of the left eye was 3.55 mm with a standard deviation of 1.11 mm among HIV-positive adults on HAART.
NigeriaVIH/sidaobservé October 2017 to June 2018publié 2019Nigerian journal of clinical practicePubMeddocument de 5 observations
53,4 %Out of 400 patients, 199 patients (53.4%) reported experiencing serious adverse drug reactions.
NigeriaVIH/sidapublié 2024AIDS carePubMeddocument de 3 observations
30,9 %Among 350 adult patients with HIV infection at Aminu Kano Teaching Hospital, Kano, Nigeria, 108 (30.9%) had low baseline serum cortisol levels.
NigeriaVIH/sidapublié 2019African health sciencesPubMeddocument de 3 observations
49,2 %Unintended pregnancy prevalence was 49.2% among women living with HIV in Cross River State, Nigeria.
NigeriaVIH/sidaobservé 2024publié 2026BMC public healthPubMeddocument de 4 observations
3,5 %The prevalence of prolonged QRS interval was 3.5% in HIV-positive children.
NigeriaVIH/sidapublié 2020The Nigerian postgraduate medical journalPubMeddocument de 9 observations
43,6 %Less than half (43.6%) of HIV-positive male partners participated in PMTCT.
NigeriaVIH/sidapublié 2020Current HIV researchPubMeddocument de 5 observations
22 %Among 91 HIV-1 infected individuals in Abakaliki metropolis, Ebonyi State, Nigeria, 20 (22.0%) were positive for Epstein-Barr Nuclear Antigen (EBNA) IgM antibody.
NigeriaVIH/sida · virus Epstein-Barrpublié 2020Journal of immunoassay & immunochemistryPubMeddocument de 15 observations
32,8 %Among 85 known PLHIV not on treatment in NAIIS, 32.8% self-linked to care.
NigeriaVIH/sidaobservé 2018publié 2021PloS onePubMeddocument de 13 observations
84,46 %The prevalence of good virological outcome was 84.46% among HIV-infected individuals on HAART in three treatment facilities in Osogbo, Southwest Nigeria.
NigeriaVIH/sidapublié 2025BMC infectious diseasesPubMeddocument de 2 observations
0,594 AORPatients residing in urban areas had an adjusted odds ratio of 0.594 for TB/HIV coinfection.
Nigeriatuberculose · VIH/sidaobservé 2018-2022publié 2024BMJ openPubMeddocument de 6 observations
65,8 %Among 1,598 people living with HIV (PLHIV) on antiretroviral therapy (ART) in three states in southern Nigeria surveyed between July and August 2019, 65.8% were willing to pay for ART consultation.
NigeriaVIH/sidaobservé July and August 2019publié 2023PloS onePubMeddocument de 9 observations
95,5 %95.5% of the respondents had a good perception of the quality of care they received.
NigeriaVIH/sidaobservé December 2020 to March 2021publié 2023Journal of the International Association of Providers of AIDS CarePubMeddocument de 2 observations
40,6 %The prevalence of latent tuberculosis infection among HIV-infected patients was 40.6% using tuberculin skin test.
Nigerialatent tuberculosis infection · VIH/sidapublié 2021The Pan African medical journalPubMeddocument de 5 observations
85 %About 85% of women were treated with first line highly active retroviral therapy (HAART).
NigeriaVIH/sidapublié 2023BMC women's healthPubMeddocument de 5 observations
20,37 per_100_person_yearsLost-to-follow-up incidence decreased significantly from 20.37 per 100 person-years in 2020 to 0.69 per 100 person-years in 2022.
NigeriaVIH/sidaobservé 2020publié 2025PloS onePubMeddocument de 8 observations
77,5 %77.5% of respondents reported exposure to at least one type of HIV prevention intervention.
NigeriaVIH/sidapublié 2023PloS onePubMeddocument de 3 observations
83,3 %Among 425 adult PLHIVs attending a tertiary hospital in Nigeria, 354 (83.3%) had optimal HAART adherence (≥ 95%).
NigeriaVIH/sidapublié 2020Ghana medical journalPubMeddocument de 7 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.